Sandoz Group AG

SDZ.SW·Swiss·Healthcare
Compare
82.98+0.84 (+1.02%)today
As of Nov 5, 12:34 PM CET · May be delayed up to 15 min · CHF

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close82.14
Open82.74
Day range82.2683.60
52-week range52.5285.62
Off day high−0.74%
Off 52-week high−3.08%
Volume217.47K
Avg. volume (3M)1.33M
Market cap35.90B
EPS (TTM)1.17
Forward P/E21.60
P/E ratio (TTM)70.92
Dividend yield0.97% (0.8000)
Beta (5Y)0.46
Shares outstanding432.69M
Short interest—
Earnings dateAug 5, 2026
Analyst target80.01
Profit margin5.53%

Against its peers

Compare in full ›
SDZ.SW MRK.F 3KY.F 000230.KS 000623.SZ 1795.TW
Market cap 35.90B 65.87B 22.96B 65.20B 20.71B 44.76B
P/E (TTM) 70.9 27.8 29.1 — 6.8 11.8
Forward P/E 21.6 16.7 — — 7.9 7.1
Price/book 4.9 2.2 4.6 — 0.6 1.9
Dividend yield 0.97% 1.49% 1.54% 1.79% 2.88% 1.61%
1-year change +51.44% +37.23% −9.11% −52.38% −16.84% −42.88%
Today +1.02% +0.50% 0.00% +0.89% −0.35% +5.66%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

Latest news

All SDZ.SW news ›
Seeking Alpha·Positive

Sandoz Group AG (SDZNY) Q3 2026 Sales/Trading Call Transcript

Sandoz Group AG (SDZNY) Q3 2026 Sales/Trading Call October 28, 2026 4:30 AM EDT Craig Marks - Head of Investor RelationsRichard Saynor - Chief Executive OfficerRemco Steenbergen - Chief Financial Officer Good morning, ladies and gentlemen,…

Seeking Alpha·Negative

Sandoz falls as headwinds in Germany prompt cautious outlook

Sandoz (SDZNY) stock dropped as the company cuts its outlook with its Q3 2026 sales, which also fell short of forecasts amid market headwinds in Germany. Read more here. Shares of Sandoz (SDZNY) (SDZXF) closed lower in Europe on Tuesday…

TradingView·Positive

Sandoz Group Ltd News — XETR:D8Y

Sandoz Group AG engages in focusing on generic pharmaceuticals and bio similar medical products. It acquires, manages and sells investments and intellectual property in the healthcare and medical device industry and conducts all business…

@law360·

States Win 1st OK Of $400M Sandoz Generic Price-Fixing Deal

Law360 States Win 1st OK Of $400M Sandoz Generic Price-Fixing Deal By Brian Steele · October 16, 2026, 5:37 PM EDT /healthcare-authority/tracked_cases?case_id=5852d2620b3a4c66f0000001&case_title=Connecticut+et+al+v.+Aurobindo+Pharma+USA%2

CVS

From the 4Search news index, newest first.

In the news

12mentions in 30 days
12with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance